Pfizer pharmaceuticals news

Pfizer will pay $2.3 billion as part of a settlement with the U.S. Department of Justice to settle investigations related to past off-label promotional practices. The amount includes a $1.3 billion criminal penalty related to Bextra valdecoxib. The second-generation cyclooxygenase-2 (COX-2)

Read the full 410 word article

How to gain access

Continue reading with a
two-week free trial.